Use of a triple helix-forming oligodeoxynucleotides as a novel therapeutic strategy for ERB-B2 positive breast cancer
Dolan, C.
Use of a triple helix-forming oligodeoxynucleotides as a novel therapeutic strategy for ERB-B2 positive breast cancer - 1998. - Staff Publications Staff Publications- Hollywood, Donal .